Gene · 7068
Papers3,032
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,032
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Coexistence of Resistance to Thyroid Hormone and a Thyroid Stimulating Hormone-Secreting Pituitary Adenoma. | AACE Endocrinol Diabetes | 2026 | 41641293 | PubTator, text mining | PubMed |
| TSP50 attenuates metabolic dysfunction-associated steatotic liver disease via SCD1 degradation-mediated suppression of hepatocyte lipogenesis. | Cell Mol Biol Lett | 2026 | 41622160 | PubTator, text mining | PubMed |
| DEHP-associated toxic targets in endometrial carcinoma: prognostic value and immunological implications. | Int J Environ Health Res | 2026 | 41616042 | PubTator, text mining | PubMed |
| Dietary supplement based on dihydromyricetin in metabolic dysfunction-associated steatotic liver disease: a double-blind, placebo-controlled, randomized clinical trial. | Ann Gastroenterol | 2026 | 41612982 | PubTator, text mining | PubMed |
| Unlocking Ethiopia's genomic landscape and its global significance: a call for inclusive genomics research. | Hum Genomics | 2026 | 41612491 | PubTator, text mining | PubMed |
| The metabolic dysfunction-associated steatohepatitis (MASH) drug resmetirom exhibits broad nuclear receptor activity with minimal functional impact. | Sci Rep | 2026 | 41611794 | PubTator, text mining | PubMed |
| The evolution of gene regulation in mammalian cerebellum development. | Science | 2026 | 41610256 | PubTator, text mining | PubMed |
| Advances in pharmacological interventions for hepatic fibrosis: from pathogenic mechanisms to novel therapeutic targets. | Ann Med | 2026 | 41588833 | PubTator, text mining | PubMed |
| [Resistance to thyroid hormone syndrome with developmental disorders in two children]. | Zhongguo Dang Dai Er Ke Za Zhi | 2026 | 41582758 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screen identifies ACSL3 as a regulator of lipotoxicity and progression of MASLD. | Hepatol Commun | 2026 | 41564380 | PubTator, text mining | PubMed |
| Machine Learning Models for High-Throughput Screening of Obesogens Based on Pathway Network. | Environ Health (Wash) | 2026 | 41562031 | PubTator, text mining | PubMed |
| <p>Beyond hepatic stellate cell heterogeneity: Resolving fibrosis, restoring regeneration (Review)</p>. | Int J Mol Med | 2026 | 41543176 | PubTator, text mining | PubMed |
| How to efficiently characterize the interaction pathways of protein-ligand recognition? A comparative analysis on enhanced sampling approaches. | J Chem Phys | 2026 | 41511038 | PubTator, text mining | PubMed |
| Decabromodiphenyl ethane, a flame retardant, acts as a thyroid hormone receptor antagonist. | Toxicol Res | 2026 | 41503439 | PubTator, text mining | PubMed |
| Targeting THR-β for MASLD Treatment: Current Progression and Emerging Prospects. | J Med Chem | 2026 | 41489920 | PubTator, text mining | PubMed |
| Transcriptome-wide association study of sex effects identifies sex-specific nasal epithelial gene expression profiles for total IgE. | J Allergy Clin Immunol | 2026 | 41482249 | PubTator, text mining | PubMed |
| Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities. | Gut | 2026 | 41475978 | PubTator, text mining | PubMed |
| Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review. | JAMA | 2026 | 41212550 | PubTator, text mining | PubMed |
| Differential expression of long non-coding RNA in the hypothalamus-pituitary-gonadal axis of Wanxi white geese during laying and broodiness periods. | Anim Biosci | 2026 | 41132064 | PubTator, text mining | PubMed |
| Deciphering pathogenic mechanisms of BDCPP exposure in endometrial cancer progression via an integrated approach combining network toxicology, machine learning, and molecular docking. | Int J Surg | 2026 | 40990645 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7068/papers?page=6